Frick Amber, Benton Cristina, Suzuki Oscar, Dong Olivia, Howard Rachel, El-Sabae Hijrah, Wiltshire Tim
Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
Pharmacy (Basel). 2018 Oct 23;6(4):115. doi: 10.3390/pharmacy6040115.
Pharmacogenomics provides a personalized approach to pharmacotherapy by using genetic information to guide drug dosing and selection. However, partly due to lack of education, pharmacogenomic testing has not been fully implemented in clinical practice. With pharmacotherapy training and patient accessibility, pharmacists are ideally suited to apply pharmacogenomics to patient care. Student pharmacists ( = 222) participated in an educational intervention that included voluntary personal genotyping using 23andMe. Of these, 31% of students completed both pre- and post-educational interventions to evaluate their attitudes and confidence towards the use of pharmacogenomics data in clinical decision making, and 55% of this paired subset obtained personal genotyping. McNemar's test and the Wilcoxon signed-rank test were used to analyze responses. Following the educational intervention, students regardless of genotyping were more likely to recommend personal genotyping (36% post-educational intervention versus 19% pre-educational intervention, = 0.0032), more confident in using pharmacogenomics in the management of drug therapy (51% post-educational intervention versus 29% pre-educational intervention, = 0.0045), and more likely to believe that personalized genomics would have an important role in their future pharmacy career (90% post-educational intervention versus 51% pre-educational intervention, = 0.0072) compared to before receiving the educational intervention. This educational intervention positively influenced students' attitudes and confidence regarding pharmacogenomics in the clinical setting. Future studies will examine the use of next-generation sequencing assays that selectively examine pharmacogenes in the education of student pharmacists.
药物基因组学通过利用基因信息来指导药物剂量和选择,提供了一种个性化的药物治疗方法。然而,部分由于缺乏教育,药物基因组学检测在临床实践中尚未得到充分实施。凭借药物治疗培训和患者可及性,药剂师非常适合将药物基因组学应用于患者护理。222名药学专业学生参与了一项教育干预,其中包括使用23andMe进行自愿个人基因分型。在这些学生中,31%的学生完成了教育干预前后的评估,以评价他们对在临床决策中使用药物基因组学数据的态度和信心,并且在这个配对子集中,55%的学生进行了个人基因分型。使用McNemar检验和Wilcoxon符号秩检验来分析回答。教育干预后,无论是否进行基因分型,学生更有可能推荐个人基因分型(教育干预后为36%,教育干预前为19%,P = 0.0032),在药物治疗管理中使用药物基因组学时更有信心(教育干预后为51%,教育干预前为29%,P = 0.0045),并且相比于接受教育干预之前,更有可能认为个性化基因组学在他们未来的药学职业生涯中将发挥重要作用(教育干预后为90%,教育干预前为51%,P = 0.0072)。这种教育干预对学生在临床环境中关于药物基因组学的态度和信心产生了积极影响。未来的研究将考察在药学专业学生教育中使用选择性检测药物基因的下一代测序分析方法。